Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹4,851 Cr
down ₹80.6 Cr vs Mar 2022
- Stocks held
- 27
- up 2 vs Mar 2022
- Top 10 weight
- 69.7%
- of the portfolio in its ten largest
- Cash & debt
- 1.3%
- cash, money market and debt
- Moves this month
- 2 in · 0 out
- added to 10, trimmed 14
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In April 2022 it disclosed 27 stocks worth ₹4,851 Cr, down ₹80.6 Cr from Mar 2022. Its largest positions were Sun Pharmaceutical Industries Limited (14.0%), Cipla Limited (8.5%), Divi's Laboratories Limited (7.9%); the ten largest together made up 69.7% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 78.4% of its equity. Cash and debt stood at 1.3%. Compared with Mar 2022 the fund entered 2 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
95%
Top-10 weight is higher than 95% of peers
Breadth
10%
Holds more stocks than 10% of peers
Cash
18%
Holds more cash than 18% of peers
Holdings in April 2022
Download CSVEvery line the fund disclosed, with the change against Mar 2022. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 13.98%
- Δ weight
- up 0.43 pts
- Value
- ₹678 Cr
- Δ value
- up ₹10.1 Cr
- Status
- Added
- Weight
- 8.49%
- Δ weight
- down 0.18 pts
- Value
- ₹412 Cr
- Δ value
- down ₹15.5 Cr
- Status
- Trimmed
- Weight
- 7.89%
- Δ weight
- up 0.31 pts
- Value
- ₹383 Cr
- Δ value
- up ₹8.8 Cr
- Status
- Added
- Weight
- 7.31%
- Δ weight
- down 0.17 pts
- Value
- ₹355 Cr
- Δ value
- down ₹14 Cr
- Status
- Trimmed
- Weight
- 6.60%
- Δ weight
- up 0.09 pts
- Value
- ₹320 Cr
- Δ value
- down ₹1 Cr
- Status
- Held
- Weight
- 6.14%
- Δ weight
- up 0.15 pts
- Value
- ₹298 Cr
- Δ value
- up ₹2.4 Cr
- Status
- Added
- Weight
- 5.98%
- Δ weight
- down 0.62 pts
- Value
- ₹290 Cr
- Δ value
- down ₹35.2 Cr
- Status
- Trimmed
- Weight
- 5.02%
- Δ weight
- down 0.10 pts
- Value
- ₹243 Cr
- Δ value
- down ₹8.9 Cr
- Status
- Trimmed
- Weight
- 4.54%
- Δ weight
- down 0.21 pts
- Value
- ₹220 Cr
- Δ value
- down ₹13.8 Cr
- Status
- Trimmed
- Weight
- 3.77%
- Δ weight
- down 0.26 pts
- Value
- ₹183 Cr
- Δ value
- down ₹15.9 Cr
- Status
- Trimmed
- Weight
- 3.68%
- Δ weight
- down 0.91 pts
- Value
- ₹179 Cr
- Δ value
- down ₹47.6 Cr
- Status
- Trimmed
- Weight
- 3.31%
- Δ weight
- down 0.19 pts
- Value
- ₹161 Cr
- Δ value
- down ₹12.1 Cr
- Status
- Trimmed
- Weight
- 3.30%
- Δ weight
- down 0.31 pts
- Value
- ₹160 Cr
- Δ value
- down ₹17.7 Cr
- Status
- Trimmed
- Weight
- 3.00%
- Δ weight
- up 1.43 pts
- Value
- ₹146 Cr
- Δ value
- up ₹68.1 Cr
- Status
- Added
- Weight
- 2.95%
- Δ weight
- down 0.09 pts
- Value
- ₹143 Cr
- Δ value
- down ₹7.1 Cr
- Status
- Trimmed
- Weight
- 2.12%
- Δ weight
- up 0.07 pts
- Value
- ₹103 Cr
- Δ value
- up ₹1.6 Cr
- Status
- Added
- Weight
- 1.81%
- Δ weight
- up 0.05 pts
- Value
- ₹88 Cr
- Δ value
- up ₹90 L
- Status
- Added
- Weight
- 1.77%
- Δ weight
- down 0.01 pts
- Value
- ₹85.9 Cr
- Δ value
- down ₹2 Cr
- Status
- Trimmed
- Weight
- 1.68%
- Δ weight
- up 0.10 pts
- Value
- ₹81.3 Cr
- Δ value
- up ₹3.5 Cr
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 1.33%
- Δ weight
- down 0.84 pts
- Value
- ₹64.6 Cr
- Δ value
- down ₹42.4 Cr
- Status
- Trimmed
- Weight
- 1.25%
- Δ weight
- down 0.12 pts
- Value
- ₹60.8 Cr
- Δ value
- down ₹6.9 Cr
- Status
- Trimmed
- Weight
- 0.76%
- Δ weight
- up 0.18 pts
- Value
- ₹36.7 Cr
- Δ value
- up ₹8.1 Cr
- Status
- Added
- Weight
- 0.74%
- Δ weight
- up 0.16 pts
- Value
- ₹36 Cr
- Δ value
- up ₹7.4 Cr
- Status
- Added
- Weight
- 0.54%
- Δ weight
- down 0.03 pts
- Value
- ₹26.4 Cr
- Δ value
- down ₹1.8 Cr
- Status
- Trimmed
- Weight
- 0.54%
- Δ weight
- up 0.54 pts
- Value
- ₹26.1 Cr
- Δ value
- up ₹26.1 Cr
- Status
- New
- Weight
- 0.54%
- Δ weight
- up 0.10 pts
- Value
- ₹26 Cr
- Δ value
- up ₹4.6 Cr
- Status
- Added
- Weight
- 0.50%
- Δ weight
- up 0.50 pts
- Value
- ₹24.2 Cr
- Δ value
- up ₹24.2 Cr
- Status
- New
- Weight
- 0.47%
- Δ weight
- down 0.08 pts
- Value
- ₹22.6 Cr
- Δ value
- down ₹4.4 Cr
- Status
- Trimmed
What changed, Mar 2022 to Apr 2022
New New positions (2)
- Ajanta Pharma Limited0.5% · ₹26.1 Cr
- Rainbow Childrens Medicare Limited0.5% · ₹24.2 Cr
Exited Exited (0)
None.
Added Biggest additions
- JB Chemicals & Pharmaceuticals Limitedup ₹68.1 Cr (+1.43% pts)
- Sun Pharmaceutical Industries Limitedup ₹10.1 Cr (+0.43% pts)
- Divi's Laboratories Limitedup ₹8.8 Cr (+0.31% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Mar 2022, the weight rose most in Pharmaceuticals & Biotechnology (+1.6 pts), and fell most in Healthcare Services (−1.6 pts).
- Pharmaceuticals & Biotechnology76.8% → 78.4%+1.6 pts
- Healthcare Services20.8% → 19.3%−1.6 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Apr 2021 | Oct 2021 | Jan 2022 | Mar 2022 | Apr 2022 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 80.6% | 76.2% | 75.3% | 76.8% | 78.4% |
| Healthcare Services | 16.4% | 21.6% | 22.3% | 20.8% | 19.3% |
| Pharmaceuticals | 2.3% | 2.2% | 1.8% | 1.8% | 1.8% |
| Healthcare Equipment & Supplies | — | — | 0.5% | 0.6% | 0.6% |
Allocation in Apr 2022change vs Mar 2022
- Pharmaceuticals & Biotechnology (18)78.4%▲ 1.6 pts
- Healthcare Services (7)19.3%▼ 1.6 pts
- Pharmaceuticals (1)1.8%
- Healthcare Equipment & Supplies (1)
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Apr 2022
1.3%
▼ 0.8 pts vs Mar 2022
- Cash alone
- 1.3%
- cash and net receivables
- A year earlier
- 3.3%
- Apr 2021 · now ▼ 2.0 pts
- Last 12 months
- 0.4% – 5.9%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.